-
Experts say a twice-yearly injection that offers 100% protection against HIV is ‘stunning'
A study shows that a twice-yearly shot was 100% effective in preventing new HIV infections in women in Africa. The shot is already used in the U.S. and elsewhere as a treatment for the virus that causes AIDS, and drugmaker Gilead is testing it for prevention.
-
Scientists say they have identified a root cause of lupus — one that could pave the way for new treatments
A study published Wednesday in the journal Nature outlines a clear pathway for how the disease likely develops, pointing to abnormalities in the immune systems of people with lupus.
-
What cognitive tests can show — and what they can't
President Joe Biden is under pressure to undergo cognitive testing even though his physician says he gets, and passes, an annual neurologic exam. But what can the brief screening tool actually tell about a person’s brain health? And when does the average older adult need one?
-
FDA approves a second Alzheimer's drug that can modestly slow disease
U.S. health officials have approved a new Alzheimer’s drug that can modestly slow the disease.
-
Getting rid of poison ivy is a serious matter. What you should and shouldn't do
Poison ivy poses a serious problem for many who come into contact with it. What you should and shouldn’t do.
-
Beyond Ozempic: New GLP-1 drugs promise weight loss and health benefits
Researchers at the American Diabetes Association conference in Orlando are expected to present data on 27 GLP-1 drugs in development. Others target a different hormone.
-
Brain science start-up Neuroelectrics uses electricity and a headcap to reduce seizures in patients with epilepsy. Now it needs FDA approval
Neuroelectrics is developing therapies it says will improve the lives of people living with brain disease.
-
Moderna's combination Covid, flu vaccine is more effective than existing shots in late-stage trial
Moderna is the first company to release positive phase three data on a Covid and flu combination shot, giving it a lead over rivals Pfizer and Novavax.
-
Male birth control gel is safe and effective, new trial findings show
After decades of attempts to develop new birth control medications for men, scientists are more hopeful than ever. With new abortion restrictions, demand is growing, experts say.
-
Cancer patients often do better with less intensive treatment, new research finds
Scaling back treatment for some cancers can make life easier for patients without hurting the outcomes.
-
Woman has pig kidney transplant removed 47 days after operation
Doctors say a woman who received a pig kidney transplant is back on dialysis after surgeons removed the gradually failing organ.
-
Bilingual AI brain implant helps stroke survivor communicate in Spanish and English
Scientists at the University of California, San Francisco have developed a bilingual brain implant that uses artificial intelligence to help a stroke survivor communicate in Spanish and English for the first time.
-
Here's what it's like inside the operating room when someone gets a brain implant
Precision Neuroscience is testing its brain implant at the Mount Sinai Health System in New York City. CNBC observed one procedure from the operating room.
-
A psychology expert's No. 1 tip on how to use your fear of death to live your best life
“I think we can tune into the fact that we’re temporary and not make it morbid,” a psychology expert told CNBC Make It.
-
Can pink noise enhance sleep and memory? Early research drives a color noise buzz
You’ve probably heard of white noise. Now pink noise, brown noise — a whole rainbow of sounds –are providing competition.
-
US pediatricians group reverses decades-old ban on breastfeeding for those with HIV
A top U.S. pediatricians’ group is making a sharp policy change about breastfeeding by people with HIV.
-
Tick season has arrived. Protect yourself with these tips
Tick season is starting across the U.S., and experts are warning the bloodsuckers may be as plentiful as ever. Here’s a look at what’s expected this year and how you can protect yourself.
-
New menopause drugs treat hot flashes, but women may face insurance hurdles
New drugs to treat debilitating menopause symptoms — namely hot flashes — are finally on the market or are in development. But doctors say insurance companies either won’t pay for them or make women try and fail with other, perhaps less effective, drugs before they do.
-
A subset of Alzheimer's cases may be caused by two copies of a single gene, new research shows
A gene called APOE4 has long been considered a key risk factor. But new research says if people inherit two copies of that gene, it’s not just a risk — it appears to be the underlying cause.
-
Pregnancy-related deaths are dropping. Here's why doctors aren't satisfied.
The number of women dying while pregnant is returning to pre-pandemic levels following a worrisome 2021 spike, a new report from the Centers for Disease Control and Prevention shows.